# AbbVie

- Headquarters: United States
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Sites

| Place | Latest | Largest value | Types |
| --- | --- | --- | --- |
| Tuas Biomedical Park, Singapore | 2024-01-25 | $223.0M | expansion |
| Ballytivnan, Ireland | 2018-01-16 | $139.0M | expansion |

## Customers, suppliers and deals

- [iSTAR Medical](https://endata.com/companies/64264.md): partner, 2×, latest 2022-09-20
- [NEXGEL](https://endata.com/companies/10317.md): supplier, 1×, latest 2023-10-30

## Announcements (6)

- 2024-01-25: [AbbVie expands biologics manufacturing capacity in Singapore with $223M investment](https://endata.com/announcements/85176-abbvie-expands-biologics-manufacturing-capacity-in-singapore-with-223m) (Expansion · Tuas Biomedical Park, Singapore, Singapore · $223.0M · 100 jobs · starts operating 2026)
- 2023-10-30: [NEXGEL subsidiary signs supply agreement with AbbVie for gel pads](https://endata.com/announcements/82478-nexgel-subsidiary-signs-supply-agreement-with-abbvie-for-gel-pads) (Contract · United States)
- 2022-09-20: [iSTAR Medical and AbbVie enter strategic alliance for MINIject device](https://endata.com/announcements/71531-istar-medical-and-abbvie-enter-strategic-alliance-for-miniject-device) (Partnership · $60.0M)
- 2022-07-20: [AbbVie and iSTAR Medical form strategic alliance for glaucoma treatment](https://endata.com/announcements/69963-abbvie-and-istar-medical-form-strategic-alliance-for-glaucoma-treatment) (Partnership · $60.0M)
- 2021-12-16: [Allergan Aesthetics completes acquisition of Soliton](https://endata.com/announcements/64117-allergan-aesthetics-completes-acquisition-of-soliton) (Acquisition · United States)
- 2018-01-16: [AbbVie expands oncology manufacturing facility in Sligo, Ireland](https://endata.com/announcements/27973-abbvie-expands-oncology-manufacturing-facility-in-sligo-ireland) (Expansion · Ballytivnan, Sligo, Ireland · $139.0M · 100 jobs)

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
